107 related articles for article (PubMed ID: 6363851)
1. Inhibitors of calf-brain enkephalinase A and B.
van Amsterdam JG; van Buuren KJ; de Jong AM; Soudijn W
Life Sci; 1983; 33 Suppl 1():109-12. PubMed ID: 6363851
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum.
van Amsterdam JG; van Buuren KJ; Soudijn W
Biochem Biophys Res Commun; 1983 Sep; 115(2):632-41. PubMed ID: 6578795
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W
Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201
[TBL] [Abstract][Full Text] [Related]
4. Effect of various enkephalin analogs and dipeptides on the enzymatic activity of enkephalinase B isolated from calf-brain striatum.
van Amsterdam JG; van Buuren KJ; Koomen AP; Soudijn W
Life Sci; 1986 Mar; 38(12):1111-8. PubMed ID: 3515091
[TBL] [Abstract][Full Text] [Related]
5. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
6. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors.
Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP
Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
Altstein M; Blumberg S; Vogel Z
Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
[TBL] [Abstract][Full Text] [Related]
8. Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides.
Llorens C; Gacel G; Swerts JP; Perdrisot R; Fournie-Zaluski MC; Schwartz JC; Roques BP
Biochem Biophys Res Commun; 1980 Oct; 96(4):1710-6. PubMed ID: 7004444
[No Abstract] [Full Text] [Related]
9. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H
Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of an enkephalin-hydrolyzing dipeptidyl-aminopeptidase from calf-brain striatum.
van Buuren KJ; van Amsterdam JG; Mulder JR; Soudijn W
Neuropeptides; 1985 Sep; 6(5):381-9. PubMed ID: 3903539
[TBL] [Abstract][Full Text] [Related]
11. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
[TBL] [Abstract][Full Text] [Related]
12. Propioxatins A and B, new enkephalinase B inhibitors. IV. Characterization of the active site of the enzyme using synthetic propioxatin analogues.
Inaoka Y; Naruto S
J Biochem; 1988 Nov; 104(5):706-11. PubMed ID: 3069842
[TBL] [Abstract][Full Text] [Related]
13. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
Altstein M; Bachar E; Vogel Z; Blumberg S
Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
[TBL] [Abstract][Full Text] [Related]
14. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
15. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
[TBL] [Abstract][Full Text] [Related]
16. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.
Fournié-Zaluski MC; Lucas-Soroca E; Devin J; Roques BP
J Med Chem; 1986 May; 29(5):751-7. PubMed ID: 3517331
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of enkephalinase B from rat brain membrane.
Inaoka Y; Tamaoki H
Biochim Biophys Acta; 1987 Jul; 925(1):27-35. PubMed ID: 3297170
[TBL] [Abstract][Full Text] [Related]
18. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
Roques BP
J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
[TBL] [Abstract][Full Text] [Related]
19. Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand.
De la Baume S; Schwartz JC
Eur J Pharmacol; 1988 Apr; 149(1-2):121-9. PubMed ID: 3165067
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain.
Cushman DW; Gordon EM; Wang FL; Cheung HS; Tung R; Delaney NG
Life Sci; 1983; 33 Suppl 1():25-8. PubMed ID: 6319870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
